Immunosenescence and gender: A study in healthy Cubans

Immunity and Ageing

Volumn 10, Issue 1, 2013, Pages

  García Verdecia, Beatriz ^a   Saavedra Hernández, Danay ^a   Lorenzo Luaces, Patricia ^a   de Jesús Badía Alvarez, Teresita ^a   Leonard Rupalé, Idrissa ^a   Mazorra Herrera, Zaima ^a   Crombet Ramos, Tania ^a   Lage Dávila, Agustín ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CUBA; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; HUMAN CELL; INFANT MORTALITY; LEUKOCYTE; LIFE EXPECTANCY; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE; VACCINATION;

EID: 84876792738     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-10-16     Document Type: Article

References (64)

1. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19(4):408-415. 10.1016/j.coi.2007.06.004, 17656078.
2. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol 2009, 21(4):418-424. 10.1016/j.coi.2009.05.023, 2725188, 19570667.
3. Pawelec G, Solana R. Immunosenescence. Immunol Today 1997, 18(11):514-516. 10.1016/S0167-5699(97)01145-6, 9386344.
4. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 2002, 37(2-3):445-453.
5. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121(1-3):187-201.
6. Akbar AN, Fletcher JM. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 2005, 17(5):480-485. 10.1016/j.coi.2005.07.019, 16098721.
7. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73(11):975-983.
8. Libri V, Azevedo RI, Jackson SE, Di Mitri D, Lachmann R, Fuhrmann S, Vukmanovic-Stejic M, Yong K, Battistini L, Kern F. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology 2011, 132(3):326-339. 10.1111/j.1365-2567.2010.03386.x, 3044899, 21214539.
9. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985, 22(5):563-575. 10.1111/j.1365-3083.1985.tb01916.x, 4081647.
10. Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol 2000, 20(4):250-256. 10.1023/A:1006611518223, 10939712.
11. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, Neuman B, Wurzner R, Grubeck-Loebenstein B. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007, 68(2):86-90. 10.1016/j.humimm.2006.10.019, 17321897.
12. Pido-Lopez J, Imami N, Aspinall R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin Exp Immunol 2001, 125(3):409-413. 10.1046/j.1365-2249.2001.01640.x, 1906152, 11531948.
13. Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A, Abolhassani H, Massoud A. Naive CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012, 22(3):160-167.
14. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 2008, 9(5):299-308. 10.1007/s10522-008-9138-6, 18369735.
15. Yan J, Greer JM, Hull R, O'Sullivan JD, Henderson RD, Read SJ, McCombe PA. The effect of ageing on human lymphocyte subsets: comparison of males and females. Immun Ageing 2010, 7:4. 10.1186/1742-4933-7-4, 2858100, 20233447.
16. Pawelec G. Hallmarks of human " immunosenescence" : adaptation or dysregulation?. Immun Ageing 2012, 9(1):15. 10.1186/1742-4933-9-15, 3416738, 22830639.
17. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?. Nat Rev Immunol 2011, 11(4):289-295. 10.1038/nri2959, 21436838.
18. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg M, Cohen D, Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994, 29(6):601-609. 10.1016/0531-5565(94)90073-6, 9435913.
19. Huppert FA, Solomou W, O'Connor S, Morgan K, Sussams P, Brayne C. Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp Gerontol 1998, 33(6):593-600. 10.1016/S0531-5565(98)00033-3, 9789736.
20. Weng NP. Aging of the immune system: how much can the adaptive immune system adapt?. Immunity 2006, 24(5):495-499. 10.1016/j.immuni.2006.05.001, 2266981, 16713964.
21. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ. T cell subset-specific susceptibility to aging. Clin Immunol 2008, 127(1):107-118. 10.1016/j.clim.2007.12.002, 2435295, 18222733.
22. Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines 2008, 7(4):467-479. 10.1586/14760584.7.4.467, 18444893.
23. Kern F, Khatamzas E, Surel I, Frommel C, Reinke P, Waldrop SL, Picker LJ, Volk HD. Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999, 29(9):2908-2915. 10.1002/(SICI)1521-4141(199909)29:09<2908::AID-IMMU2908>3.0.CO;2-8, 10508265.
24. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009, 155(3):423-432. 10.1111/j.1365-2249.2008.03785.x, 2669518, 19220832.
25. Roberts ET, Haan MN, Dowd JB, Aiello AE. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010, 172(4):363-371. 10.1093/aje/kwq177, 2950794, 20660122.
26. Solana R, Tarazona R, Aiello AE, Akbar AN, Appay V, Beswick M, Bosch JA, Campos C, Cantisan S, Cicin-Sain L. CMV and Immunosenescence: from basics to clinics. Immun Ageing 2012, 9(1):23. 10.1186/1742-4933-9-23, 3585851, 23114110.
27. De Vos P, Garcia-Farinas A, Alvarez-Perez A, Rodriguez-Salva A, Bonet-Gorbea M, Van der Stuyft P. Public health services, an essential determinant of health during crisis. Lessons from Cuba, 1989-2000. Trop Med Int Health 2012, 17(4):469-479. 10.1111/j.1365-3156.2011.02941.x, 22296108.
28. Coyula M. Havana: aging in an aging city. MEDICC Rev 2010, 12(4):27-29.
29. Kouri V, Correa CB, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, Perez L, Golpe MA, Someilan T, Chong Y. Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis J 2010, 29(12):1105-1110. 10.1097/INF.0b013e3181eb7388, 20622711.
30. Marrero M, Alvarez M, Suarez L, Diaz-Jidi M, Kouri V. Serologic response to some herpesviruses in a group of HIV infected patients. Rev Cubana Med Trop 1992, 44(3):208-211.
31. Resik S, Enamorado A, Tallo Y, Suarez C, Kouri V, Acosta B, Garcia S. Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus and cytomegalovirus in a group of patients after hemodialysis. Rev Cubana Med Trop 1999, 51(3):172-176.
32. Glenn J. Cytomegalovirus infections following renal transplantation. Rev Infect Dis 1981, 3(6):1151-1178. 10.1093/clinids/3.6.1151, 6281874.
33. Dorshkind K, Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr Opin Immunol 2009, 21(4):404-407. 10.1016/j.coi.2009.07.001, 2742656, 19632102.
34. Bender BS, Tallman E. The heterogeneity of the age-related decline in immune response: impairment in delayed-type hypersensitivity and cytotoxic T-lymphocyte activity occur independently. Exp Gerontol 1992, 27(3):347-354. 10.1016/0531-5565(92)90061-4, 1639154.
35. Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, Blomberg BB. B cells and aging: molecules and mechanisms. Trends Immunol 2009, 30(7):313-318. 10.1016/j.it.2009.04.005, 2766868, 19540810.
36. Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 1984, 5(3):435-455. 10.1210/edrv-5-3-435, 6381037.
37. Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, Woloszczuk W, Peterlik M, Tragl KH. The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol 2003, 38(10):1119-1127. 10.1016/S0531-5565(03)00189-X, 14580865.
38. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001, 2(9):777-780. 10.1038/ni0901-777, 11526384.
39. McCarthy M. The " gender gap" in autoimmune disease. Lancet 2000, 356(9235):1088. 10.1016/S0140-6736(05)74535-9, 11009154.
40. Beagley KW, Gockel CM. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38(1):13-22. 10.1016/S0928-8244(03)00202-5, 12900050.
41. Hince M, Sakkal S, Vlahos K, Dudakov J, Boyd R, Chidgey A. The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 2008, 252(1-2):122-138.
42. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985, 121(3):531-551. 1887926, 3907369.
43. Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol 1984, 132(2):656-661.
44. Lotter H, Jacobs T, Gaworski I, Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect Immun 2006, 74(1):118-124. 10.1128/IAI.74.1.118-124.2006, 1346632, 16368964.
45. Mock BA, Nacy CA. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 1988, 56(12):3316-3319. 259743, 3182082.
46. Lenkei R, Andersson B. High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors. Clin Immunol Immunopathol 1995, 77(2):131-138. 10.1006/clin.1995.1136, 7586720.
47. Merino J, Martinez-Gonzalez MA, Rubio M, Inoges S, Sanchez-Ibarrola A, Subira ML. Progressive decrease of CD8high+ CD28+ CD57- cells with ageing. Clin Exp Immunol 1998, 112(1):48-51. 10.1046/j.1365-2249.1998.00551.x, 1904936, 9566789.
48. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169(4):1984-1992.
49. Wills MR, Okecha G, Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol 2002, 168(11):5455-5464.
50. Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJ, Slagboom EP, Westendorp RG, Pawelec G. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 2011, 92(Pt 12):2746-2756.
51. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002, 8(4):379-385. 10.1038/nm0402-379, 11927944.
52. Gamadia LE, Rentenaar RJ, Baars PA, Remmerswaal EB, Surachno S, Weel JF, Toebes M, Schumacher TN, ten Berge IJ, van Lier RA. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001, 98(3):754-761. 10.1182/blood.V98.3.754, 11468176.
53. Pita-Lopez ML, Gayoso I, DelaRosa O, Casado JG, Alonso C, Munoz-Gomariz E, Tarazona R, Solana R. Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun Ageing 2009, 6:11. 10.1186/1742-4933-6-11, 2741428, 19715573.
54. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007, 81(14):7759-7765. 10.1128/JVI.01262-06, 1933343, 17409149.
55. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005, 175(12):8218-8225.
56. Correa CB, Kouri V, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, Perez L, Viera J, Gonzalez R, Perez E. HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn 2010, 30(9):888-892. 10.1002/pd.2587, 20715119.
57. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 396(6712):690-695. 10.1038/25374, 9872319.
58. Aspinall R, Pido J, Andrew D. A simple method for the measurement of sjTREC levels in blood. Mech Ageing Dev 2000, 121(1-3):59-67.
59. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999, 283(5406):1277-1278. 10.1126/science.283.5406.1277, 10084932.
60. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Franceschi C, Caruso C. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002, 3(1):30-33. 10.1038/sj.gene.6363827, 11857058.
61. Balistreri CR, Candore G, Accardi G, Bova M, Buffa S, Bulati M, Forte GI, Listi F, Martorana A, Palmeri M. Genetics of longevity. data from the studies on Sicilian centenarians. Immun Ageing 2012, 9(1):8. 10.1186/1742-4933-9-8, 3402998, 22524430.
62. Garcia B, Neninger E, de la Torre A, Leonard I, Martinez R, Viada C, Gonzalez G, Mazorra Z, Lage A, Crombet T. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. Clin Cancer Res 2008, 14(3):840-846. 10.1158/1078-0432.CCR-07-1050, 18245547.
63. Candore G, Balistreri CR, Listi F, Grimaldi MP, Vasto S, Colonna-Romano G, Franceschi C, Lio D, Caselli G, Caruso C. Immunogenetics, gender, and longevity. Ann N Y Acad Sci 2006, 1089:516-537. 10.1196/annals.1386.051, 17261795.
64. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128(1):83-91. 10.1016/j.mad.2006.11.015, 17118425.